 Transplantation, Heterologous
"Transplantation, Heterologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation between animals of different species.
| Descriptor ID |
D014183
|
| MeSH Number(s) |
E04.936.764
|
| Concept/Terms |
Transplantation, Heterologous- Transplantation, Heterologous
- Heterografting
- Xenotransplantation
- Xenograft Transplantation
- Transplantation, Xenograft
- Xenografting
- Heterograft Transplantation
- Transplantation, Heterograft
- Heterologous Transplantation
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Heterologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Heterologous".
This graph shows the total number of publications written about "Transplantation, Heterologous" by people in this website by year, and whether "Transplantation, Heterologous" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2015 | 0 | 1 | 1 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Transplantation, Heterologous" by people in Profiles.
-
Chung C, Sweha SR, Pratt D, Tamrazi B, Panwalkar P, Banda A, Bayliss J, Hawes D, Yang F, Lee HJ, Shan M, Cieslik M, Qin T, Werner CK, Wahl DR, Lyssiotis CA, Bian Z, Shotwell JB, Yadav VN, Koschmann C, Chinnaiyan AM, Bl?ml S, Judkins AR, Venneti S. Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas. Cancer Cell. 2020 09 14; 38(3):334-349.e9.
-
Bi Q, Ranjan A, Fan R, Agarwal N, Welch DR, Weinman SA, Ding J, Iwakuma T. MTBP inhibits migration and metastasis of hepatocellular carcinoma. Clin Exp Metastasis. 2015 Apr; 32(4):301-11.
-
Waibel M, Solomon VS, Knight DA, Ralli RA, Kim SK, Banks KM, Vidacs E, Virely C, Sia KC, Bracken LS, Collins-Underwood R, Drenberg C, Ramsey LB, Meyer SC, Takiguchi M, Dickins RA, Levine R, Ghysdael J, Dawson MA, Lock RB, Mullighan CG, Johnstone RW. Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors. Cell Rep. 2013 Nov 27; 5(4):1047-59.
-
Behbod F, Kittrell FS, LaMarca H, Edwards D, Kerbawy S, Heestand JC, Young E, Mukhopadhyay P, Yeh HW, Allred DC, Hu M, Polyak K, Rosen JM, Medina D. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res. 2009; 11(5):R66.
-
Donjon CM, Morkowski H, Cheung RK, Leeder JS, Dosch HM. Reversion of the SCID phenotype by human T cell grafts. Development of cross-species immunocompetence. J Immunol. 1993 Dec 01; 151(11):5948-54.
-
Dosch HM, Cochrane DM, Cook VA, Leeder JS, Cheung RK. Exogenous but not endogenous EBV induces lymphomas in beige/nude/xid mice carrying human lymphoid xenografts. Int Immunol. 1991 Jul; 3(7):731-5.
-
O'Hara BM, Klinger HP, Curran T, Zhang YD, Blair DG. Levels of fos, ets2, and myb proto-oncogene RNAs correlate with segregation of chromosome 11 of normal cells and with suppression of tumorigenicity in human cell hybrids. Mol Cell Biol. 1987 Aug; 7(8):2941-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|